Active material: L-ornithine L-aspartate
When ATH: A05BA
CCF: Gipoammoniemichesky drug
ICD-10 codes (testimony): K72, K73
When CSF: 11.16.05.02
Manufacturer: Merz Pharma GmbH & Co. KGaA (Germany)
◊ Granules for oral solution as a mixture of granules and orange white.
| 1 again. (5 g) | |
| L-ornithine L-aspartate | 3 g |
Excipients: Citric acid anhydrous, lemon flavor, orange flavor, sodium saccharin (saccharin sodium), sodium cyclamate, colorant sunset yellow, polyvinylpyrrolidone (povidone), fructose (levulose).
5 г – пакетики (10) – коробки картонные.
5 г – пакетики (30) – коробки картонные.
Gipoammoniemichesky drug. It reduces elevated levels of ammonia in the body, in particular, liver diseases. The operation is linked to its participation in the ornithine cycle of urea Krebs (formation of urea from ammonia).
It contributes to the development of insulin and growth hormone. It improves protein metabolism in diseases, requiring parenteral nutrition.
Орнитин аспартат диссоциирует на составляющие его компоненты – аминокислоты орнитин и аспартат, are absorbed in the small intestine by active transport across the intestinal epithelium. Excreted in the urine through a cycle of urea.
- Acute and chronic liver disease, accompanied by hyperammonemia;
- Hepatic encephalopathy (latent or expressed).
The drug is prescribed inside of 1 sachet of granules, dissolved in 200 ml of liquid, 2-3 times / day, postprandial.
From the digestive system: в отдельных случаях – тошнота, vomiting.
Other: allergic reactions.
- Severe renal insufficiency (sыvorotochnыy creatinine > 3 mg / 1 for);
- Lactation (breast-feeding);
- Hypersensitivity to the drug.
The drug should be used with caution during pregnancy.
The drug is contraindicated during breast-feeding.
In hepatic encephalopathy must be careful when driving and occupation of other potentially hazardous activities, require high concentration and speed of psychomotor reactions.
Symptoms: increased severity of side effects.
Treatment: gastric lavage, administration of activated charcoal, symptomatic therapy.
Drug Interactions drug Hepa-Merz is not described.
The drug is resolved to application as an agent Valium holidays.
The drug should be stored out of reach of children at or above 25 ° C. Shelf life - 5 years.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More